Related Experiment Video

Updated: May 28, 2026

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

Suppression of extrapyramidal side effects of doxepin by thalamic deep brain stimulation for Tourette syndrome

L Rzesnitzek1, T Wächter, R Krüger

  • 1Department of Psychiatry and Psychotherapy, University of Tübingen, Osianderstrasse 24, D-72076 Tübingen, Germany.

Neurology
|November 2, 2011
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
09:46

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus

Published on: March 8, 2015

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Related Experiment Videos

Last Updated: May 28, 2026

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
09:46

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus

Published on: March 8, 2015

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Articles linked to this work by shared authors, journal, and citation graph.

Quality management and specifications of multidisciplinary Parkinson's disease management: an expert opinion.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Parkinson´s day-clinic: which patients should be selected and what services should be offered for successful therapy?

Journal of neural transmission (Vienna, Austria : 1996)·2025

Urinary Biomarkers Of Kidney Function As Predictors Of Cardiovascular Health: A Systematic Review.

Current hypertension reports·2025

Allostatic load and cardiometabolic health in a young adult South African population: the African-PREDICT study.

American journal of physiology. Heart and circulatory physiology·2025

Strong connectivity to the sensorimotor cortex predicts clinical effectiveness of thalamic deep brain stimulation in essential tremor.

NeuroImage. Clinical·2024

Education as Risk Factor of Mild Cognitive Impairment: The Link to the Gut Microbiome.

The journal of prevention of Alzheimer's disease·2024

Comparative Effectiveness of Treatments for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Neurology·2026

Physical Activity and Motor and Cognitive Progression in Parkinson Disease: A Longitudinal Cohort Study.

Neurology·2026

Portable Ultra-Low-Field MRI in Neurologic Diseases: Current Status and Potential in Clinical Practice, Research, and Trials.

Neurology·2026

Contraceptive and Enzyme-Inducing Antiseizure Medication Coprescription Among US Medicaid Beneficiaries With Epilepsy.

Neurology·2026

Quantitative Relationship Between Lumipulse G Measures of pTau217 in Plasma and the Temporal Cortex.

Neurology·2026

Dual Antiglutamate Therapy in Super-Refractory Status Epilepticus After Cardiac Arrest (SUPER-CAT Study).

Neurology·2026

Mechanism-aware and explainable artificial intelligence for drug release prediction in polymeric drug delivery systems.

Frontiers in medicine·2026

Continuous Subcutaneous Apomorphine as a Temporary Bridging Therapy for Dopamine Dysregulation Syndrome in Patients with Deep Brain Stimulation.

Movement disorders clinical practice·2026

Polar vs Non-polar Excipients in BSA Aggregation.

Pharmaceutical research·2026

Applying pharmacokinetic and pharmacodynamic concepts from human clinical anesthesia to laboratory animal anesthesia.

Experimental animals·2026

Mapping the Alignment Between the Portuguese Pharmacotherapeutic Assessment Methodology and EU Joint Clinical Assessment Guidance.

Therapeutic innovation & regulatory science·2026

Triphosphate and diphosphate nucleoside prodrugs: broadening the therapeutic potential of nucleoside-based treatments.

RSC medicinal chemistry·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us